FGFR3-IN-5
FGFR3-IN-5 is a potent and selective FGFR3 inhibitor with IC50 values of 3, 44, and 289 nM for FGFR3, FGFR2, and FGFR1, respectively. FGFR3-IN-5 can be used in research of cancer[1].
Product Specifications
CAS Number
[2446664-72-6]
UNSPSC
12352005
Target
FGFR
Type
Reference compound
Related Pathways
Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/fgfr3-in-5.html
Concentration
10mM
Purity
99.16
Solubility
DMSO : 100 mg/mL (ultrasonic; warming; heat to 160°C)
Smiles
N#CC1=C2C(OC)=CC(C3=CN(C4CCN(CC4)C(C5(CN(C5)C(C=C)=O)F)=O)N=C3)=CN2N=C1
Molecular Formula
C24H24FN7O3
Molecular Weight
477.49
References & Citations
[1]James FB, et, al. Substituted pyrazolo[1,5-a]pyridine compounds as inhibitors of fgfr tyrosine kinases. WO2020131627.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
EPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (HRP)
EPHB4 (HTK, MYK1, TYRO11, EPH Receptor B4, Ephrin Receptor EphB4, Hepatoma Transmembrane Kinase, Soluble EPHB4 Variant 1, Soluble EPHB4 variant 2, Soluble EPHB4 Variant 3) (HRP)
Lentiviral human MAGEB5 sgRNA gene knockout kit - Lentiviral human MAGEB5 sgRNA gene knockout kit (25)